Pharmacology News

I’ve been a primary care provider now for 37 years, but I still remember my early days of residency well.

Vitamin D3 supplementation was not associated with reduced statin-associated muscle symptoms compared with placebo among new statin users enrolled in the VITAL trial, according to a trial subanalysis published in JAMA Cardiology.

For healthy older patients, an aspirin a day does not reduce fracture risk and might increase the risk for serious falls, according to researchers.

The FDA announced findings from a preliminary assessment that indicate certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.

SER-109, an investigational oral microbiome therapeutic, was well-tolerated and durably reduced rates of recurrent Clostridioides difficile infection through 24 weeks, with benefits showing as early as week 2, data show.

CHICAGO — An ultra-low-dose four-drug quad therapy may improve BP control among patients with hypertension, with no increased safety risk, compared with angiotensin receptor blocker monotherapy, according to a small, first-in-U.S. study.

The CDC has released updated and expanded clinical practice guidance on prescribing opioids to patients with short- and long-term pain.

Compared with other direct oral anticoagulants, apixaban was associated with lower rates of gastrointestinal bleeding but similar rates of ischemic stroke and all-cause mortality among adults with atrial fibrillation, data show.

Despite a downward trend in overall opioid use, disparities persist among members of the LGBTQ+ community, according to a study presented at the American Society of Anesthesiologists’ annual meeting.

BOSTON — The medical community is better equipped to combat residual CVD risk than previously, but prevention of residual risk should be tailored using a precision medicine approach, a speaker said at the Cardiometabolic Health Congress.